Landscapes / Targets
FGF21R
2 drugs act on FGF21R, in 7 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Apr 2028Phase 2 trial completes | |||
| Next date | Apr 2028 · Phase 2 trial completes | ||||
| Also tested for | Hypertriglyceridemia, MASLD and 2 more | ||||
| Open drug page | |||||
— |
Hoffmann-La Roche +1 |
Phase 3 | 30 Jun 2028Phase 3 trial completes | ||
| Next date | 30 Jun 2028 · Phase 3 trial completes | ||||
| Also tested for | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026